AU1809499A - Self-emulsifying fenofibrate formulations - Google Patents

Self-emulsifying fenofibrate formulations

Info

Publication number
AU1809499A
AU1809499A AU18094/99A AU1809499A AU1809499A AU 1809499 A AU1809499 A AU 1809499A AU 18094/99 A AU18094/99 A AU 18094/99A AU 1809499 A AU1809499 A AU 1809499A AU 1809499 A AU1809499 A AU 1809499A
Authority
AU
Australia
Prior art keywords
self
fenofibrate formulations
emulsifying
emulsifying fenofibrate
formulations
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU18094/99A
Inventor
Awadhesh K. Mishra
Iskandar Moussa
Indu Parikh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
RTP PHARMA Inc
Original Assignee
RTP PHARMA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by RTP PHARMA Inc filed Critical RTP PHARMA Inc
Publication of AU1809499A publication Critical patent/AU1809499A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Emergency Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU18094/99A 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations Abandoned AU1809499A (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US98827097A 1997-12-10 1997-12-10
US08988270 1997-12-10
US4994298A 1998-03-30 1998-03-30
US09049942 1998-03-30
PCT/US1998/026075 WO1999029300A1 (en) 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations

Publications (1)

Publication Number Publication Date
AU1809499A true AU1809499A (en) 1999-06-28

Family

ID=26727723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU18094/99A Abandoned AU1809499A (en) 1997-12-10 1998-12-10 Self-emulsifying fenofibrate formulations

Country Status (2)

Country Link
AU (1) AU1809499A (en)
WO (1) WO1999029300A1 (en)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6337092B1 (en) 1998-03-30 2002-01-08 Rtp Pharma Inc. Composition and method of preparing microparticles of water-insoluble substances
EP1067914B1 (en) 1998-03-30 2006-02-22 Jagotec Ag Composition and method of preparing microparticles of water-insoluble substances
JP2002513750A (en) * 1998-05-07 2002-05-14 エラン コーポレーシヨン ピーエルシー Solvent / co-solvent free microemulsion and emulsion pre-concentrate drug delivery system
CA2367995A1 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
WO2000057859A1 (en) * 1999-03-31 2000-10-05 Abbott Laboratories Novel formulations comprising lipid-regulating agents
US6372251B2 (en) * 1999-06-11 2002-04-16 Abbott Laboratories Formulations comprising lipid-regulating agents
US6982281B1 (en) 2000-11-17 2006-01-03 Lipocine Inc Pharmaceutical compositions and dosage forms for administration of hydrophobic drugs
JP2003509453A (en) * 1999-09-21 2003-03-11 アールティーピー・ファーマ・インコーポレーテッド Surface-modified granular compositions of biologically active substances
AU2006201100B2 (en) * 1999-09-21 2009-09-24 Jagotec Ag Surface modified particulate compositions of biologically active substances
EP1408930A1 (en) * 1999-10-20 2004-04-21 Vesifact Ag Microemulsion preconcentrates which contain cyclosporines and corresponding microemulsions
FR2803203B1 (en) * 1999-12-31 2002-05-10 Fournier Ind & Sante NEW GALENIC FORMULATIONS OF FENOFIBRATE
EP1118333A1 (en) * 2000-01-18 2001-07-25 Eurand International S.P.A. Compositions with enhanced oral bioavailability
US7276249B2 (en) 2002-05-24 2007-10-02 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
US20030224058A1 (en) * 2002-05-24 2003-12-04 Elan Pharma International, Ltd. Nanoparticulate fibrate formulations
GB0119480D0 (en) * 2001-08-09 2001-10-03 Jagotec Ag Novel compositions
EP1539117A4 (en) * 2002-06-28 2005-12-14 Shire Lab Inc Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
US20040005339A1 (en) * 2002-06-28 2004-01-08 Shojaei Amir H. Formulations of fenofibrate and/or fenofibrate derivatives with improved oral bioavailability
US8003690B2 (en) 2002-12-13 2011-08-23 Jagotec Ag Topical nanoparticulate spironolactone formulation
US20050074469A1 (en) * 2003-10-03 2005-04-07 Charles Signorino Stable lipophilic emulsions for acrylic coating and method of making
WO2005037251A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self-emulsifying drug delivery systems for hydrophobic therapeutic compounds
WO2005037250A1 (en) * 2003-10-17 2005-04-28 Amylin Pharmaceuticals, Inc. Self emulsifying drug delivery systems for hydrophobic therapeutic compounds
CA2537029C (en) * 2003-11-26 2013-03-12 Likan Liang Micellar systems useful for delivery of lipophilic or hydrophobic compounds
US7790190B2 (en) * 2004-03-20 2010-09-07 Yasoo Health, Inc. Aqueous emulsions of lipophile solubilized with vitamin E TPGS and linoleic acid
CA2573316A1 (en) * 2004-08-06 2006-02-16 Transform Pharmaceuticals, Inc. Novel fenofibrate formulations and related methods of treatment
US8026281B2 (en) 2004-10-14 2011-09-27 Lupin Atlantis Holdings, S.A. Treating metabolic syndrome with fenofibrate
US7772277B2 (en) 2005-08-04 2010-08-10 Transform Pharmaceuticals, Inc. Formulations comprising fenofibrate and a statin, and related methods of treatment
WO2008144355A2 (en) * 2007-05-17 2008-11-27 Morton Grove Pharmaceuticals, Inc. Stable, self-microemulsifying fenofibrate compositions
US11304960B2 (en) 2009-01-08 2022-04-19 Chandrashekar Giliyar Steroidal compositions
US11395811B2 (en) 2009-03-09 2022-07-26 Pronova Biopharma Norge As Compositions comprising a fatty acid oil mixture comprising EPA and DHA in free acid form and a surfactant, and methods and uses thereof
EP2442805A4 (en) * 2009-06-19 2012-11-21 Sun Pharma Advanced Res Co Ltd Nanodispersion of a drug and process for its preparation
US20180153904A1 (en) 2010-11-30 2018-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US9034858B2 (en) 2010-11-30 2015-05-19 Lipocine Inc. High-strength testosterone undecanoate compositions
US9358241B2 (en) 2010-11-30 2016-06-07 Lipocine Inc. High-strength testosterone undecanoate compositions
US20120148675A1 (en) 2010-12-10 2012-06-14 Basawaraj Chickmath Testosterone undecanoate compositions
EP2878311A1 (en) * 2013-11-27 2015-06-03 Freund Pharmatec Ltd. Solubility Enhancement for Hydrophobic Drugs
WO2016033556A1 (en) 2014-08-28 2016-03-03 Lipocine Inc. BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS
WO2016033549A2 (en) 2014-08-28 2016-03-03 Lipocine Inc. (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE
CN108014170A (en) * 2016-11-04 2018-05-11 珠海天凯生物科技有限公司 Wild marjoram oil emu and preparation method thereof
EP3544614A4 (en) 2016-11-28 2020-08-05 Lipocine Inc. Oral testosterone undecanoate therapy
AU2019308326A1 (en) 2018-07-20 2021-03-18 Lipocine Inc. Liver disease
CN109431999B (en) * 2018-12-18 2021-02-19 华南农业大学 A kind of nanometer self-microemulsion, veterinary drug nanometer self-microemulsion and its preparation method and application

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3421468A1 (en) * 1984-06-08 1985-12-19 Dr. Rentschler Arzneimittel Gmbh & Co, 7958 Laupheim LIPID NANOPELLETS AS A CARRIER SYSTEM FOR MEDICINAL PRODUCTS FOR PERORAL USE
FR2617047B1 (en) * 1987-06-23 1991-05-10 Sanofi Sa TANNING RESISTANT GELATIN COMPOSITION, CAPSULES BASED ON THIS COMPOSITION AND THEIR PHARMACEUTICAL APPLICATION, IN PARTICULAR TO FENOFIBRATE
FR2627696B1 (en) * 1988-02-26 1991-09-13 Fournier Innovation Synergie NEW GALENIC FORM OF FENOFIBRATE
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US5545628A (en) * 1995-01-10 1996-08-13 Galephar P.R. Inc. Pharmaceutical composition containing fenofibrate
FR2730231B1 (en) * 1995-02-02 1997-04-04 Fournier Sca Lab COMBINATION OF FENOFIBRATE AND VITAMIN E, USE IN THERAPEUTICS
FR2737121B1 (en) * 1995-07-27 1997-10-03 Cl Pharma NEW GALENIC FORMULATIONS OF FENOFIBRATE AND THEIR APPLICATIONS

Also Published As

Publication number Publication date
WO1999029300A1 (en) 1999-06-17

Similar Documents

Publication Publication Date Title
AU1809499A (en) Self-emulsifying fenofibrate formulations
AU1617399A (en) Glp-1 formulations
AU7389098A (en) Local anesthetic formulations
AU6244098A (en) Distributed game
AU6562298A (en) Peptide-enhanced transfections
AU7582298A (en) Tissue specific prodrug
AU3345195A (en) Surface-active formulations
AU3345295A (en) Surface-active formulations
AU5875098A (en) Processor
AU6042298A (en) Tissue factor pathway inhibitor-3
AUPO714197A0 (en) Multi-strategy array processor
AU7265596A (en) Probiotically acting formulations
AUPO907397A0 (en) Game
AU3902895A (en) Solid glyphosate formulations
AU3261297A (en) New insecticide formulations
AU3129097A (en) Explosive formulations
AU7604096A (en) Gameboard
AU8233098A (en) Game
AUPM926794A0 (en) Herbicidal formulations
AU8155898A (en) Human preprotachykinin b
AU1645599A (en) Human matrilin-3
AU3069697A (en) Explosive formulations
AU9338498A (en) Chair
AU718511C (en) Glyphosate liquid formulations
AU3129197A (en) Explosive formulations

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase